Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 16 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (2)
P 2 (6)
P 3 (1)

Trial Status

Completed14
Unknown1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06837038Not ApplicableEnrolling By Invitation

Clinical Study of Rhythmic Auditory Stimulation for Gait Disorders

NCT04193527Phase 3CompletedPrimary

A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

NCT04925622Completed

Complex Eye Movements in Parkinson's Disease and Related Movement Disorders

NCT05110547Unknown

Multicenter Study of Blood Biomarkers of Mitochondrial and Peroxisomal Metabolism to Differentiate Idiopathic Parkinson's Disease From Related Conditions

NCT04974034Completed

Movement Disorders Analysis Using a Deep Learning Approach

NCT00354003CompletedPrimary

The Study of the Impact of Disclosing Imaging Study Information to Trial Participants

NCT00096876Completed

A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients

NCT00132626Phase 2Completed

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

NCT00368199Completed

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

NCT00129675Phase 2CompletedPrimary

Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty

NCT00315250Phase 2Completed

Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease

NCT00273351Phase 2Completed

Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families

NCT00117819Phase 2CompletedPrimary

A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease

NCT00117195Completed

A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease

NCT00096720Phase 2Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

NCT00129181Not ApplicableCompleted

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Showing all 16 trials

Research Network

Activity Timeline